Literature DB >> 21939988

[Rhabdomyolysis. A descriptive study of 449 patients].

Jacinto Herráez García1, Aldo Mateo Torracchi Carrasco, Ana Cristina Antolí-Royo, Rebeca de la Fuente Blanco, Maria Teresa Santos Jiménez.   

Abstract

BACKGROUND AND OBJECTIVES: Rhabdomyolysis is a clinical syndrome characterized by acute necrosis of skeletal muscles along with the release of breakdown products into the bloodstream. Rhabdomyolysis is potentially lethal and its most serious complication is acute renal failure (ARF). Diagnosis is established by the 5-times elevation (975 UI/l) over the upper limit of creatine-kinase (CK). PATIENTS AND METHODS: We performed a retrospective study on Salamanca University Hospital for the period 1999-2010. There were 449 patients diagnosed with rhabdomyolysis over which we tested demographic, etiologic, analytic, complication and mortality variables.
RESULTS: Out of 449 patients, 69% were male. Average age was 66.5 ± 21 years. Most frequent etiologies were trauma, sepsis and immobility/crushing (24, 19 and 17% respectively). Maximum levels of CK were 343,170 ng/ml and its increase did not show significant association with mortality or ARF. This was found in 54% of patients (mean creatinine 3.03 mg/dl) and it was significantly associated with mortality (P <. 001). Global mortality was 18.7%. There were no significant associations between mortality and unique or multiple causes. However, there were significant associations between mortality and age (P <. 001) and 90% of deaths occurred among patients over 60 years old.
CONCLUSION: Rhabdomyolysis prevails in elder males. Trauma, sepsis and immobility/crushing are the most frequent etiologies. CK values are not related with ARF or mortality. Mortality is associated with most frequent causes, old age and ARF.
Copyright © 2011 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21939988     DOI: 10.1016/j.medcli.2011.05.021

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  4 in total

1.  Lipid metabolism disorders, lymphocytes cells death, and renal toxicity induced by very low levels of deoxynivalenol and fumonisin b1 alone or in combination following 7 days oral administration to mice.

Authors:  J H Kouadio; S Moukha; K Brou; D Gnakri
Journal:  Toxicol Int       Date:  2013-09

Review 2.  Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice.

Authors:  Luis O Chavez; Monica Leon; Sharon Einav; Joseph Varon
Journal:  Crit Care       Date:  2016-06-15       Impact factor: 9.097

3.  Characteristics of pediatric rhabdomyolysis and the associated risk factors for acute kidney injury: a retrospective multicenter study in Korea.

Authors:  Sukdong Yoo; Min Hyun Cho; Hee Sun Baek; Ji Yeon Song; Hye Sun Lee; Eun Mi Yang; Kee Hwan Yoo; Su Jin Kim; Jae Il Shin; Keum Hwa Lee; Tae-Sun Ha; Kyung Mi Jang; Jung Won Lee; Kee Hyuck Kim; Heeyeon Cho; Mee Jeong Lee; Jin-Soon Suh; Kyoung Hee Han; Hye Sun Hyun; Il-Soo Ha; Hae Il Cheong; Hee Gyung Kang; Mee Kyung Namgoong; Hye-Kyung Cho; Jae-Hyuk Oh; Sang Taek Lee; Kyo Sun Kim; Joo Hoon Lee; Young Seo Park; Seong Heon Kim
Journal:  Kidney Res Clin Pract       Date:  2021-08-17

4.  The etiology of rhabdomyolysis: an interaction between genetic susceptibility and external triggers.

Authors:  N Kruijt; L R van den Bersselaar; E J Kamsteeg; W Verbeeck; M M J Snoeck; D S Everaerd; W F Abdo; D R M Jansen; C E Erasmus; H Jungbluth; N C Voermans
Journal:  Eur J Neurol       Date:  2020-10-25       Impact factor: 6.089

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.